ISRCTN - ISRCTN14886370: ImpulsePal: A feasibility study of to aid the planning of a randomised controlled trial and refinement of a smartphone app-based intervention to support weight loss

Plain English Summary

Background and study aims
Obesity continues to be a growing burden to society and healthcare providers. It increases the risk of chronic health problems such as heart disease, diabetes, and other diseases. Weight loss can greatly reduce the risk of such health problems. Interventions to promote weight loss are available. However, people often struggle to lose weight, despite strong intentions to do so. This is thought to be due at least to food choices that occur impulsively with little conscious awareness. Based on the views of people struggling with weight management, behaviour change experts and published research, an intervention has been developed to help people develop skills to modify the influence of impulses or “food cravings” on their eating behaviour. ImpulsePal is a smartphone app that focuses on training people to identify when (and where) cravings are likely to occur and to use several techniques to gain more control over them. The aims of the study are to develop and refine the intervention, to test the feasibility of delivering this intervention alongside several existing weight loss programmes, and to evaluate recruitment, retention, and other procedures that will be used in a future larger study of the intervention.

Who can participate?
People aged 16 and over with a body mass index (BMI) of 30kg/m2 or more

What does the study involve?
Participants are randomly allocated to one of two groups (an intervention group and a control group). The intervention group receive the ImpulsePal app and the control group are provided with access to the ImpulsePal app after the end of their study participation. Changes in body weight and other outcomes of interest are measured at 1 and 3 months after the start of the study. Participants are interviewed about their experiences of using the ImpulsePal app as well as their experiences of the research procedures, to help make both the intervention itself and the planned future study more acceptable and effective.

What are the possible benefits and risks of participating?
Possible benefits include weight loss and associated health benefits as well as health benefits associated with reduced sugar intake.

Where is the study run from?
University of Exeter (UK)

When is the study starting and how long is it expected to run for?
April 2015 to October 2017

Who is funding the study?
National Institute for Health Research (NIHR) (UK)

Who is the main contact?
Samantha van Beurden
s.b.vanbeurden@exeter.ac.uk

Trial website

Contact information

Type

Scientific

Primary contact

Miss Samantha van Beurden

ORCID ID

http://orcid.org/0000-0001-7848-2159

Contact details

Smeall building
St Luke's
Heavitree Rd
Exeter
EX1 2LU
United Kingdom
+44 (0)1392 726440
s.b.vanbeurden@exeter.ac.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

19486

Study information

Scientific title

ImpulsePal: A feasibility study to aid the planning of a randomised controlled trial and refinement of a smartphone app-based intervention to support weight loss

Acronym

ImpulsePal

Study hypothesis

Obesity continues to be a growing burden to society and healthcare providers. It increases the risk of chronic health problems such as heart disease, diabetes, and other diseases. Weight loss can greatly reduce the risk of such health problems. Interventions to promote weight loss are available. However, people often struggle to lose weight, despite strong intentions to do so. This is thought to be due, at least to food choices occur impulsively with little conscious awareness. Based on the views of people struggling with weight management, behaviour change experts, and published research we have developed an intervention to help individuals develop skills to modify the influence of impulses or “food cravings” on their eating behaviour. ImpulsePal focuses on training people to identify when (and where) cravings are likely to occur and to use several techniques to gain more control over them. This study will recruit 90 people with a body mass index (BMI) of 30kg/m2 or more. The purposes of the study are a) to develop and refine the intervention n) to test the feasibility of delivering this intervention alongside several existing weight loss programmes and c) to evaluate recruitment, retention, and other procedures that will be used in a future randomised controlled trial of the intervention.

Ethics approval

NRES Committee South-West Exeter, 21/06/2015, REC ref: 15/SW/0181 and SSA ref: 15/SW/0216

Study design

Randomised; Both; Design type: Process of Care, Physical, Qualitative

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Treatment

Patient information sheet

See additional files

Condition

Specialty: Public Health, Primary sub-specialty: Public health; UKCRC code/ Disease: Metabolic and Endocrine/ Obesity and other hyperalimentation

Intervention

Participants were randomised in a 2:1 allocation ratio to the intervention or waiting list control group.
The intervention group received the ImpulsePal app following randomisation and the control group were provided with access to the ImpulsePal app at the end of their study participation. Participants were requested to take part in a baseline assessment and one- and three-month follow-up assessments.
Participants will be interviewed about their experiences of using the ImpulsePal app as well as their experiences of the research procedures. This will help make both the intervention itself, and the planned future trial, more acceptable and effective.

Intervention type

Other

Phase

Drug names

Primary outcome measures

For this feasibility RCT, the main outcomes of interest were:
1. Uptake rate (percentage of participants eligible to take part consenting to be randomised)
2. Retention rate (the percentage of randomised individuals providing data at three months)
3. The standard deviation of weight loss at three months of follow up
Other feasibility outcomes of interest were measures-completion rates (the percentage of randomised participants who completed each measure at each time point) and acceptability of the intervention and the study procedures (percent satisfied with the ImpulsePal app and study procedures).

Primary outcome for main trial (weight) was measured to estimate standard deviations to inform sample size calculation. Weight was measured objectively using calibrated Seca 899 weighing scale at baseline, 1 month, and 3 months. Height was measured using the Seca 213 portable stadiometer at baseline only to calculate BMI.

Secondary outcome measures

Secondary outcomes for the full-scale trial were also measured as follows:
1. Unhealthy snack food/drink consumption was measured using a 7-day recall 11-item food frequency questionnaire (FFQ) adapted from a questionnaire used by Churchill and Jessop (Churchill & Jessop, 2011) at baseline, 1 month, and 3 months
2. Frequency of overeating was measured using the three items from the Eating Disorder Examination Questionnaire (EDE-Q) referring to the frequency of overeating episodes and loss of control and the number of days uncontrolled eating occurred (over a period of 28 days)

Process measures for use in the full-scale trial were also used to assess their feasibility as follows:
1. Impulsiveness was measured using the short form Barratt Impulsiveness Scale (BIS-Q)
2. Food cravings were measured using the short form Food Cravings Questionnaire -Trait (FCQ-T-reduced)
3. Sensitivity to the food environment was measured using the Power of Food Scale (PFS)
4. Self-efficacy was measured using a constructed self-efficacy questionnaire which includes items referring to situations where food temptations and cravings commonly arise which make it difficult to stick to a healthy eating goal (as identified through service user involvement)
5. Fidelity checks in terms of the delivery, receipt, and enactment of the separate intervention components

Overall trial start date

11/04/2015

Overall trial end date

20/10/2017

Reason abandoned

Eligibility

Participant inclusion criteria

People were eligible to take part if they:
1. Were at least 16 years old
2. Had a BMI of 25kg/m2 or more
3. Owned an Android-based smartphone
4. Lived within a travelling distance (up to 40 minutes) from Exeter, UK

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

Planned Sample Size: 88; UK Sample Size: 88

Participant exclusion criteria

People who:
1. Are excluded by eligibility criteria of Health Promotion Devon (see 171)
2. Are currently pregnant
3. BMI of ≥45 kg/m2. When a person reaches a BMI of 45kg/m2 lifestyle modification is more complex and
challenging, requiring specialist (Tier 3) services or bariatric surgery may be recommended (National Institute for
Health and Clinical Excellence, 2006), making it unsuitable for them to take part in the current study
3. Do not speak or understand written English
4. Are participating in concurrent interventional research which may overburden the patient or confound data collection (e.g., another weight loss trial)

Recruitment start date

01/09/2015

Recruitment end date

24/04/2017

Locations

Countries of recruitment

United Kingdom

Trial participating centre

University of Exeter
EX4 4RN
United Kingdom

Sponsor information

Organisation

University of Exeter

Sponsor details

c/o Ms Gail Seymour
Research and Knowledge Transfer
Exeter
EX4 4RN
United Kingdom
-
g.m.seymour@exeter.ac.uk

Sponsor type

Hospital/treatment centre

Website

Funders

Funder type

Government

Funder name

NIHR Trainees Co-ordinating Centre (TCC); Grant Codes: NIHR-CDF-2012-05-259

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Results have been presented at UKSBM in December 2017 and the manuscript is ready for submission to now (16/04/2018).

IPD sharing statement
The data generated and/or analysed during the current study during this study will be included in the subsequent results publication.